We have partnered with the Beijing Municipal Government and Tsinghua University to launch the Global Health Drug Discovery Institute (GHDDI) in Beijing, which aims to create a world-class transformative drug discovery and translational medicine platform for global health with advanced biomedical research and development capabilities.

The first of its kind in China, the institute will tackle major diseases faced by many developing countries, including China. It will leverage China’s research and development capacity and rich talent pool to promote international cooperation and improve the existing early drug development system by serving as a bridge connecting the advanced global drug research institutions and downstream clinical developmental agencies.